Carl Walkey - Jun 9, 2021 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role: Senior Vice President
Signature: /s/ Kris McGrew, as Attorney-in-Fact for Carl Walkey
Stock symbol: NLTX
Transactions as of: Jun 9, 2021
Transactions value $: -$7,036
Form type: 4
Date filed: 6/11/2021, 04:13 PM
Previous filing: Jun 9, 2021
Next filing: Jun 17, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NLTX	Common Stock	Sale	-$7.04K	-650	-0.05%	$10.82^*	1.35M	Jun 9, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2	Represents the weighted average sale price. The lowest price at which shares were sold was $10.81 and the highest price at which shares were sold was $11.00. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Content

This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Represents the weighted average sale price. The lowest price at which shares were sold was $10.81 and the highest price at which shares were sold was $11.00. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.